Literature DB >> 29318128

Awareness of Patients and Relatives about Breast Cancer in Turkey.

Serdar Gökay Terzioğlu1, Murat Özgür Kiliç1, Gül Dağlar1.   

Abstract

Entities:  

Year:  2018        PMID: 29318128      PMCID: PMC5756589     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

Increasing the awareness and knowledge of breast cancer (BC) is the most direct way to improve women’s behavior for participating prevention programs. In this cross-sectional study, the awareness of BC was investigated in patients and relatives in a Breast-Endocrine Clinic, Ankara Numune Training and Research Hospital, Turkey between May and July 2016. The survey form was modified from a study on BC awareness of hospital staffs (1). The participants were informed about the purpose of the study and verbal informed consent was obtained from all. Among 164 participants, 75% of the participants were female, and 54.8% were under 45. Educational status was primary/secondary school (53.7%) and ≥ high school (46.3%). The majority of participants (82.9%) had no family history of BC. Age, family history, hormone replacement treatment (HRT), and early menarche were identified as a risk factor of BC by approximately 75%, 60%, 50%, and 35% of the participants, respectively. The overall success of general belief section was 80%. The comparison of answers according to age, gender, and educational status is presented in Table 1.
Table 1:

Comparison of answers about BC

Correct n (%)Wrong n (%)PCorrect n (%)Wrong n (%)P
Does age increase BC risk?Is BC a contagious disease?
Gender
Male26 (76.4)8 (13.6)0.74832 (100)0 (0)
Female90 (72.5)34 (26.5)86 (74.1)30 (25.9)0.031
Education
Primary/Secondary62 (73.8)22 (26.2)0.93358 (70.7)24 (29.6)
≥High school54 (84.4)10 (15.6)60 (90.9)6 (9.1)0.032
Age
>4553 (63.1)31 (36.9)0.04854 (73)20 (27)0.248
≤4562 (83.8)12 (16.2)59 (82)13 (18)
Does HRT increase BC risk?Is BC a fatal disease?
Gender
Male10 (29.4)24 (70.6)22 (64.7)12 (35.3)
Female66 (56.9)50 (43.1)0.04666 (56.4)51 (43.6)0.688
Education
Primary/Secondary44 (53.6)38 (46.4)50 (61)32 (39)
≥High school36 (53)32 (47)0.56936 (54.5)30 (45.5)0.577
Age
>4544 (57.9)32 (42.1)40 (54.1)34 (45.9)
≤4532 (42.1)42 (57.9)0.20446 (62.1)28 (37.9)0.480
Does family history of BC increase BC risk?Do only females have BC?
Gender
Male18 (56.2)14 (43.7)0.76824 (75)8 (25)
Female72 (60)48 (40)68 (58.6)48 (41.4)0.232
Education
Primary/Secondary48 (58.5)34 (41.5)0.89742 (48.8)44 (51.2)
≥High school42(60)28 (40)52 (78.8)14 (21.2)0.008
Age
>4546 (58.9)32 (41.1)0.96644 (59.4)30 (40.6)
≤4544 (61.1)28 (38.9)48 (64.9)26 (35.1)0.632
Does early menarche increase BC risk?
Gender
Male4 (12.5)28 (87.5)0.024
Female50 (43.1)66 (56.9)
Education
Primary/Secondary32 (39)50 (61)0.613
≥High school22 (33.3)44 (66.7)
Age
>4530 (40.5)44 (59.5)0.469
≤4524 (32.4)50 (67.6)

Chi-square/Fisher exact tests were used for statistical analyses.

P<0.05 (significance level)

Comparison of answers about BC Chi-square/Fisher exact tests were used for statistical analyses. P<0.05 (significance level) The overall awareness about BC risk factors in our study was 50%, similar to the literature (2). Age and family history were the best-known risk factors. In general, belief section, correct answer rate was higher than that in other sections. The overall awareness was better than normal population in our study. In our opinion, the overall high correct answer rate of participants pointed out that exposure to the disease forced responders to do more research on BC. Awareness of BC tends to decrease with increasing age (3). In our study, subgroup analysis about age failed to reveal a decrease, probably based on increased awareness of older responders due to the reason for doing more research BC. Gender is also a determining factor for awareness of cancers. In a study, male participants had similar knowledge about “uni-sex” cancers such as lung, but for BC, the level of awareness was determined significantly lower when age and education adjustments were made (4). In our study, questions about HRT and early menarche had a correct answer rate in females. This can be explained by the opinion that risk factors defined as “complex” seem to be more familiar with women. Educational status is also related to awareness. In our study, well-educated responders had a correct response rate of 80% higher than the literature (5). BC symptoms were often well known by our participants. As expected, the best-known symptoms were mass and change in breast shape. The weight of the correct answer from female participants also draws attention in this section. Well-educated patients with a breast disease or their relatives can be a correct source for education of general population. Initiation of the education programs for this group may be a feasible option to realize this idea.
  5 in total

1.  Evaluation of Breast Cancer Knowledge and Awareness Among Hospital Staff in a Women Heath Hospital in Turkey.

Authors:  Gökay Terzioğlu; Emre Özgü; Murat Özgür Kılıç; Yunus Yıldız; Tayfun Güngör
Journal:  J Cancer Educ       Date:  2017-03       Impact factor: 2.037

2.  Awareness of Risk Factors for Breast, Lung and Cervical Cancer in a UK Student Population.

Authors:  Susan M Sherman; Emily L Lane
Journal:  J Cancer Educ       Date:  2015-12       Impact factor: 2.037

3.  Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.

Authors:  Jeanne S Mandelblatt; Clyde B Schechter; K Robin Yabroff; William Lawrence; James Dignam; Martine Extermann; Sarah Fox; Gretchen Orosz; Rebecca Silliman; Jennifer Cullen; Lodovico Balducci
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

4.  Evaluation of breast cancer awareness among female university students in Malaysia.

Authors:  Muhammad A Hadi; Mohamed A Hassali; Asrul A Shafie; Ahmed Awaisu
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

5.  Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects.

Authors:  Ana Rute Costa; Susana Silva; Pedro Moura-Ferreira; Manuel Villaverde-Cabral; Osvaldo Santos; Isabel do Carmo; Henrique Barros; Nuno Lunet
Journal:  Health Expect       Date:  2016-02-23       Impact factor: 3.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.